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Dust Storm Fallout
Tiniest Travelers Pose Greatest Infection Threat
Dust isn’t just a nuisance—its ability to clog human airways and carry
pathogens poses a human health problem. In the sub-Saharan region
of Africa, the World Health Organization pinpointed dust storms
exacerbated by the dry season and drought as a cause of outbreaks of
meningococcal meningitis. Dust from Saharan storms can reach as
far away as Florida, with particles smaller than 2.5 µm traveling the
greatest distances. Studies have shown that human exposure to these
tiny particles is associated with human mortality, and new research
now shows that such parti-
cles are also more likely to
carry health-threatening bac-
teria [EHP 116:292–296;
Polymenakou et al.].
During a strong Saharan
dust storm in 2006, re-
searchers collected air sam-
ples in Heraklion, Crete, an
area that often feels the
effects of such storms.
Particles from the samples
were separated according to
size (>7.9 µm, 3.3–7.9 µm,
1.6–3.3 µm, 1.0–1.6 µm,
0.55–1.0 µm, or <0.55 µm)
using a machine called
a high-volume cascade
impactor. The researchers
characterized the bacteria
traveling on particles of vari-
ous sizes by taking samples
from the machine’s filters, then cloning and sequencing a strand of
DNA commonly used to identify bacteria. This process created an
inventory of the bacterial gene sequences present in each of the six
particle-size ranges. The creation of large clone libraries allows inves-
tigators to detect bacteria that are missed using culture methods, as
some bacteria are difficult to grow.
The researchers identified clones that were genetically related
to pathogens linked to human diseases such as pneumonia,
meningitis, and bacteremia, or to pathogens suspected of inducing
infections such as endocarditis. Of the sequenced clones related to
bacteria that are dangerous to humans, almost half (43%) were
found at particle sizes less than 3.3 µm. Spore-forming bacteria
such as Firmicutes dominat-
ed the particle sizes larger
than 3.3 µm. Most of these
bacteria are nonpathogenic.
The authors conclude
that the prevalence of breath-
able bacteria on small dust
particles may pose a signifi-
cant, widespread health risk
to humans, given that dust,
especially the smallest parti-
cles, is known to travel across
continents. To determine
just how much of a threat
these tiny travelers pose,
long-term studies are needed
to further investigate how
pathogens are distributed
across dust particle size, and
the distances these pathogens
can travel and still survive.
–Angela Spivey
Life after Lindane in California
Water Concentrations, Poison Control Calls
Drop Following Ban
Lindane, a persistent, highly toxic, and bioaccumulative
organochlorine insecticide, was used in agriculture and as a topical
treatment for human head lice and scabies beginning in the 1940s.
As its toxicity became better known, manufacture and use declined
in the United States; in 2002, California banned the pharmaceuti-
cal use of lindane altogether. According to a new study, that ban
appears to have resulted in steep drops in concentrations of lindane
in Southern California’s wastewater and a dramatic reduction in
calls to the California Poison Control System [EHP 116:297–302;
Humphreys et al.]. 
The most common adverse effects of lindane exposure in
humans include seizures, dizziness, and headaches. High levels of
exposure can be fatal. Although the U.S. Environmental Protection
Agency has canceled all registrations for lindane-containing com-
pounds in agriculture, the chemical is still available by prescription
as a second-line treatment for head lice in states other than
California. Its continued pharmaceutical use raises concerns about
its potential presence in wastewater effluent and drinking water. 
The research team, part of the University of California, San
Francisco, Pediatric Environmental Health Specialty Unit, exam-
ined historical lindane concentrations in several Southern
California water pollution control plants and compared them
before and after the ban. To assess the ban’s impact on human
exposures, they analyzed lindane-related calls to California’s poison
control hotline between 1998 and 2006. They searched the Medi-
Cal fee-for-service pharmacy-paid claims database and obtained
national data from Verispan, a commercial health industry data
tracker, to determine the number of lindane prescriptions issued.
The team also conducted a random survey of pediatricians to ascer-
tain both their awareness of the ban and their current treatment
preferences for scabies and head lice.
In Los Angeles County, the average wastewater concentration of
lindane in 1999 was 36 ppt. By 2006, concentrations had dropped
to almost undetectable levels throughout California. In 1998, 135
per 100,000 calls to the Poison Control System concerned lindane;
by 2006 such calls had declined to 2 per 100,000. Similarly, lindane
prescriptions fell from 114,000 in 1997 to 34 in 2002. Medical
providers reported few problems using alternative treatments such as
pyrethrins.
The study authors are encouraged by their findings but note that
lindane is still used in many countries, mostly in the developing
world, and that every ton of lindane manufactured produces about
9 tons of toxic waste. Although the U.S. Food and Drug Admin-
istration has not banned pharmaceutical lindane in the United
States, the pesticide is currently under review for inclusion in the
Stockholm Convention on Persistent Organic Pollutants, which
could eventually lead to a worldwide ban. –Valerie J. Brown
The dust storm that provided samples for Polymenakou et al.
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Prenatal Lead Exposure in Mice
Age-Related, Sex-Specific Effects Observed
Children with low-level prenatal lead exposure may suffer reduced cog-
nitive function, impaired motor ability, and visual and auditory pro-
cessing problems. Other effects, such as accelerated age-related
functional decline or delayed neurotoxicity, may become apparent in
adulthood, though few studies have examined the long-term conse-
quences of exposure. A novel animal model now reveals age-related,
male-specific, and nonmonotonic dose–response effects associated with
low-level prenatal lead exposure [EHP 116:355–361; Leasure et al.].
To model gestational lead exposure (GLE), one group of dams
received tap water or drinking solutions containing low (27 ppm),
moderate (55 ppm), or high (109 ppm) concentrations of lead
beginning 2 weeks before mating and continuing until postnatal day
10. To measure postnatal lead exposure (PLE), another group of
dams received tap water or water that contained low or moderate lev-
els of lead from birth to weaning. The offspring of both groups were
measured at birth and several times throughout the following year
for weight and blood lead concentrations. 
Blood lead levels ranged from 10 µg/dL or less in low-exposure
GLE offspring to 42 µg/dL in the high-exposure GLE group at post-
natal day 10, and from 10 µg/dL in low-exposure PLE offspring to
27 µg/dL in the high-exposure PLE group at postnatal day 21. By
postnatal day 30 for GLE offspring and postnatal day 60 for PLE
offspring, blood lead levels were no different than in controls. 
At 1 year of age, male and female offspring were assessed for
exploratory activity and interlimb balance and coordination.
Because human developmental studies have demonstrated that
males are at higher risk of deficits related to early lead exposure,
additional testing of male offspring included measuring fore-
brain and striatal levels of dopamine and its major metabolite,
3,4-dihydroxyphenylacetic acid.
Lead exposure did not affect body weight of any PLE mice or of
female GLE mice, but there was a significant inverse relationship
between lead exposure and body weight for male low-exposure and
high-exposure GLE mice (26% and 13% heavier than controls,
respectively). Male GLE mice also exhibited significantly less
exploratory activity, with a greater effect again seen in the low-
exposure group. This group also had significantly poorer balance
and coordination, lower forebrain levels of dopamine, and higher
forebrain and striatal levels of 3,4-dihydroxyphenylacetic acid.
Multiple endocrine or metabolic mechanisms that occurred dur-
ing gestational development could explain the late-onset obesity
observed at 1 year of age. The diminished exploratory activity may
reflect an altered stress response arising from lead-related changes in
the hypothalamic–pituitary–adrenal axis and dopaminergic systems.
Changes in the forebrain may also have implications for attention
deficit/hyperactivity disorder, as abnormalities in the prefrontal cor-
tex appear to underlie the disorder. Multidisciplinary behavioral,
biochemical, and molecular studies are needed to test and explain the
reported novel findings, which highlight the need for realistic life-
time dose–response assessment of toxicants. –Julia R. Barrett
Taking a Bite Out of Amalgam
Concerns?
Study Shows No Renal Effects in Children
Dental amalgam is a major source of human exposure to inorganic
mercury, which is thought to occur primarily when elemental mer-
cury from the amalgam sur-
face evaporates and is
inhaled. Prior studies provide
strong evidence that the cen-
tral nervous system and the
kidney are the primary tar-
gets of inorganic mercury.
Data from the New England
Children’s Amalgam Trial
(NECAT), a clinical trial
designed to study the possi-
ble health effects in children
of mercury-containing dental
amalgam, now indicate that
amalgam fillings’ effects on
renal function may be quite
small [EHP 116:394–399;
Barregard et al.]. 
The study, launched in
1996 in Maine and Massachusetts, is one of two parallel randomized
trials funded by the National Institute of Dental and Craniofacial
Research. These trials provide the first rigorously designed clinical
data on the effects of children’s dental exposure to mercury, a known
neuro- and nephrotoxicant. 
A group of 537 children aged 6–10 years at the start of the
trial were followed for five years. Children began the trial with no
pre-existing fillings and at least one cavity in a back tooth. The
children were randomly assigned to two groups, one receiving
only amalgam fillings in cavities in the back teeth and the other
receiving only composite fillings in the back teeth. Both groups
received the more aesthetically pleasing composite fillings in the
front teeth, conforming to current standard dental practice. 
The children showed no statistically significant differences in
several markers of toxicity to renal tubules studied—including N-
acetyl-β-D-glucosaminidase
and alpha-1-microglobulin,
both early indicators of
toxic exposure to mercury
vapor, or in γ-glutamyl
transpeptidase, which has
been shown to be affected
by toxic heavy metal expo-
sure—regardless of whether
their cavities were filled
with amalgam or with com-
posite. 
Microalbuminuria, the
occurrence of small quanti-
ties of albumin in the
urine, increased in 10 chil-
dren treated with amalgam
and in 2 treated with com-
posite fillings, but it did
not correlate with the number of amalgam fillings or with increas-
ing concentrations of mercury excreted in urine. 
Because this difference is marginally significant, the authors
note it may be due to chance. Moreover, microalbuminuria can
occur transiently as a consequence of recent vigorous play. The
results therefore appear to indicate that the use of amalgam fillings
does not cause any clear, consistent damage to kidney function in
young, developing children. –Victoria McGovern